Healthcare Expenditures Continue to Grow, Three Leading Stocks Lead the 2026 Investment Race Jun 16, 2026 Life Science
CVS Health Surges Over 25% Year-to-Date: Why Analysts Keep Lifting Its Price Targets Jun 15, 2026 Life Science
The Stock Price of UnitedHealth Group Still Falls More Than 30% from Two Years Ago, and Policy Dependency Becomes a Key Investment Consideration Jun 12, 2026 Life Science
The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year Jun 11, 2026 Life Science
Market Embraces R&D Pipeline Progress, Moderna’s Stock Soars on Cancer Vaccine Prospects Jun 9, 2026 Life Science
The Economic Outlook Clouds Over, Weighing on the Market, but Two Pharmaceutical Giants May Buck the Trend Jun 8, 2026 Life Science
Strong Demand for GLP-1 Drugs Drives Eli Lilly’s Leadership with New Oral Medication and Acquisitions Jun 4, 2026 Life Science
Gene Editing Could Become the Next “Golden Rush” in the Pharmaceutical Industry, What Does This Mean for CRISPR Therapeutics? Jun 3, 2026 Life Science
AbbVie Faces a Challenger in Johnson & Johnson, but Investors Need Not Panic Jun 3, 2026 Life Science
Bristol-Myers Squibb’s Stock Looks Cheap on the Surface, but Hidden Risks Lurk Beneath Jun 2, 2026 Life Science
